Skip to content

Neumora Therapeutics (NMRA) IPO deck

Neumora Therapeutics is a clinical-stage biopharmaceutical company that develops targeted treatments for neurobehavioral disorders.

This post is for subscribers only

Subscribe

Already have an account? Sign In

Latest